The British Society for Rheumatology
Follow Us
Join Today
Members login
About BSR
What is rheumatology?
Strategic plan
Regions
News
BSR Special Interest Groups
Contact us
Staff
President's blog
Members
Members' area
Member offers
Join BSR
Member benefits
Resources
Guidelines
Policy
Commissioning support
Useful links
Research
Audit
BSR Biologics Registers
Events
Conference
Prizes and awards
Keep up-to-date
Education
Events Diary
E-Learning
Travelling Fellowship
BSR courses and workshops
Publications
Annual reviews
Journal
Careers
Job listings
MRes and other funding
Advertise your vacancy
BSR vacancies
Patients
Joint info
Guidelines
Current BSR guidelines
Quality Standards
Draft Guidelines for Consultation
Archive
Statements on Clinical Management
Training, service provision and RCP guidelines
Mentor
Action Plan
Guidelines Under Review
Best Practice Tariffs for Rheumatoid Arthritis
Revalidation
Policy
Commissioning support
Useful links
Research
Audit
BSR Biologics Registers
Home
Resources
Guidelines
Current BSR guidelines
Printer Friendly
2012
Acute hot joint statement
and
guidelines
Revision statement on management of hot swollen joints in adults
20 July 2012
2011
BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis
May 2011
[related content added 5 July 2012]
Rituximab audit tool
BSR/BSPAR Consensus statement on biologics in adults with JIA
June 2011
2010
Principles for biologic prescribing
December 2010
Rheumatoid arthritis guidelines on safety of anti-TNF therapies
September 2010
Management of giant cell arteritis
April 2010
Rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy
March 2010
All guidelines pre 2010 are in the guidelines archive